Inluriyo 200 mg/1
imlunestrant · TABLET, FILM COATED · Eli Lilly and Company
No Recall History
Plain English
Inluriyo is a tablet, film coated containing imlunestrant at 200 mg/1, taken oral. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- Inluriyo
- Generic Name
- imlunestrant
- NDC Code (Product)
0002-1717- Manufacturer
- Eli Lilly and Company
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218881
- Drug Class
- Estrogen Receptor Antagonist [EPC]
- Marketing Start
- 09/25/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Inluriyo used for?
Inluriyo contains imlunestrant. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Inluriyo a controlled substance?
Inluriyo is not classified as a controlled substance by the DEA.
What is the generic name for Inluriyo?
The generic name for Inluriyo is imlunestrant. There are no other listed brand versions of imlunestrant.
What is the NDC code for Inluriyo 200 mg/1?
The NDC (National Drug Code) for Inluriyo 200 mg/1 is 0002-1717, listed by Eli Lilly and Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)